Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends
Muhammad Farhan Sohail,1–3 Mubashar Rehman,4,5 Hafiz Shoaib Sarwar,2 Sara Naveed,1 Omer Salman,6 Nadeem Irfan Bukhari,7 Irshad Hussain,3 Thomas J Webster,5 Gul Shahnaz21Riphah Institute of Pharmaceutical Sciences, Riphah International University, Lahore Campus, Lahore, 2Department of Pharm...
Guardado en:
Autores principales: | Sohail MF, Rehman M, Sarwar HS, Naveed S, Salman O, Bukhari NI, Hussain I, Webster TJ, Shahnaz G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/315cf62a23d74bb081c1d474a42970e4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump
por: Elizabeth M. Grimsey, et al.
Publicado: (2020) -
Styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model
por: Parayath NN, et al.
Publicado: (2016) -
Microbial Efflux Pump Inhibitors: A Journey around Quinoline and Indole Derivatives
por: Giada Cernicchi, et al.
Publicado: (2021) -
Cryo-Electron Microscopy Structure of an <named-content content-type="genus-species">Acinetobacter baumannii</named-content> Multidrug Efflux Pump
por: Chih-Chia Su, et al.
Publicado: (2019) -
Novel pH-Sensitive Urushiol-Loaded Polymeric Micelles for Enhanced Anticancer Activity
por: Zhou H, et al.
Publicado: (2020)